Delivery Order SPE2DB22D9239-SPE2DB25FDK28

Award Date 6/27/25
Potential Completion Date 7/21/25
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,667.20 and is a firm fixed-price delivery order with an ultimate completion date of May 21, 2025. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is not associated with a set-aside program. DMS...
This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML pharmaceutical products to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $3,112.22, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $9,336.66 and an ultimate completion date of February 27, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $46,683.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a period of performance through May 20, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,458.40, is a firm fixed-price delivery order for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract has an ultimate completion date of February 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
The U.S. Defense Logistics Agency (DLA) awarded a $6,224.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a large Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. This delivery order, valued at $3,112.22, is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract is a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDK28
    Delivery Order

This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $8,750.40 and an ultimate completion date of July 21, 2025. It is a firm fixed-price delivery order contract, without a set-aside designation.

DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 9/26/25, 9:44 AM